Edwards Lifesciences (EW) Long-Term Debt Repayments (2009 - 2022)

Edwards Lifesciences' Long-Term Debt Repayments history runs 12 years deep, the most recent figure standing at $100000.0 for Q4 2022.

• In Q4 2022, Long-Term Debt Repayments changed 0.0% year-over-year to $100000.0; the TTM figure through Dec 2022 stood at $200000.0 (down 97.14% YoY), while the FY2023 annual figure was $300000.0, up 50.0% from the prior year.
• Long-Term Debt Repayments was $100000.0 for Q4 2022 at Edwards Lifesciences, roughly flat from $100000.0 in the prior quarter.
• In the past five years, Long-Term Debt Repayments ranged from a high of $601.2 million in Q4 2018 to a low of -$8.7 million in Q3 2021.
• Historically, Long-Term Debt Repayments has averaged $65.5 million across 5 years, with a median of $3.8 million in 2019.
• The sharpest annual moves came in 2018 and 2021: Long-Term Debt Repayments surged 10635.71% in 2018, then sank 495.45% in 2021.
• A 5-year view of Long-Term Debt Repayments shows it stood at $601.2 million in 2018, then tumbled by 99.14% to $5.2 million in 2019, then slumped by 42.31% to $3.0 million in 2020, then tumbled by 96.67% to $100000.0 in 2021, then changed by 0.0% to $100000.0 in 2022.
• The last three Long-Term Debt Repayments figures came in at $100000.0 (Q4 2022), $100000.0 (Q2 2022), and $100000.0 (Q4 2021), per Business Quant data.